Fosun Pharma logo

Fosun Pharma

Asia, Shanghai, China, Shanghai

Description

Fosun Pharma is a pharmaceutical company.

Investor Profile

Fosun Pharma has made 9 investments, with 2 in the past 12 months and 33% as lead.

Stage Focus

  • Seed (22%)
  • Corporate Round (22%)
  • Series C (22%)
  • Debt Financing (11%)
  • Series Unknown (11%)
  • Series D (11%)

Country Focus

  • United States (44%)
  • China (33%)
  • Israel (11%)
  • United Kingdom (11%)

Industry Focus

  • Health Care
  • Biotechnology
  • Therapeutics
  • Medical Device
  • Pharmaceutical
  • Biopharma
  • Oncology
  • Life Science
  • Genetics
  • Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fosun Pharma frequently co-invest with?

Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 1
GE Healthcare
North America, Illinois, United States, Chicago
Co-Investments: 1
BXR Partners LLP
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Apricot Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Kite Pharma
North America, California, United States, Los Angeles
Co-Investments: 1
Docor International Management
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 1
Mana Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Everbright
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
Proxima Ventures Ltd
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1

What are some of recent deals done by Fosun Pharma?

Salus BioMed

Shenzhen, Guangdong, China

Salus BioMed is an innovative biomedical company that specializes in developing genetic sequencing technology and spatial omics products.

BioinformaticsBiotechnologyGeneticsMedical
Series AMay 14, 2025
Conjustar

Shanghai, Shanghai, China

Conjustar, a protein-conjugated medicine developer, has established a robust R&D pipeline through its independent and introduction efforts.

Health CareMedicalPharmaceutical
SeedJan 16, 2025
Amount Raised: $13,639,588
Fosun Kite Biotechnology

Shanghai, Shanghai, China

Fosun Kite Biotechnology develops immune cell therapy products.

BiotechnologyPharmaceutical
Corporate RoundSep 16, 2024
Amount Raised: $1,409,741
VerImmune

Baltimore, Maryland, United States

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

BiotechnologyHealth CareOncologyTherapeutics
SeedSep 20, 2023
Amount Raised: $3,125,000
Gyroscope Therapeutics

Stevenage, Herefordshire, United Kingdom

Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.

BiotechnologyGeneticsHealth CareTherapeutics
Series CMar 26, 2021
Amount Raised: $148,586,567
Fosun Kite Biotechnology

Shanghai, Shanghai, China

Fosun Kite Biotechnology develops immune cell therapy products.

BiotechnologyPharmaceutical
Corporate RoundJul 9, 2020
Amount Raised: $20,000,000
Butterfly Network

Burlington, Massachusetts, United States

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

ElectronicsHealth CareMedical DevicePersonal Health
Series DSep 27, 2018
Amount Raised: $250,000,000
Ambrx

La Jolla, California, United States

Ambrx is a clinical-stage biopharmaceutical company using expanded genetic code technology for next-gen therapies and immune modulation.

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics
Series UnknownAug 4, 2016
Amount Raised: $45,000,000
Spirosure

Pleasanton, California, United States

Spirosure develops breath-analysis devices to use novel breath-based analysis in disease diagnosis and management.

Health CareMedical Device
Series CJun 30, 2016
Amount Raised: $17,400,000
Check-Cap

Isfiyeh, Hefa, Israel

Check-Cap is a young and dynamic medical device company with breakthrough solution for Colorectal Cancer Screening.

BiopharmaBiotechnologyHealth CareMedical Device
Debt FinancingOct 19, 2014
Amount Raised: $12,000,000